Stock Screener App

Frei -

Installieren

3.02

6.21% -0.20

Vorhandelsmarkt: 3.23 0.21 +6.95%

Lixte Biotechnology Holdings Inc (LIXT)

Überblick Nachrichten Preisverlauf Financials Forum Prognose Aktiensplit

Lixte Biotechnology Holdings Inc Aktie (LIXT) Neueste Nachrichten

Improving the Odds: How LIXTE Biotechnology (LIXT) Is Working to Make Cancer Therapies More Effective - NewMediaWire

Improving the Odds: How LIXTE Biotechnology (NASDAQ: LIXT) Is Working to Make Cancer Therapies More Effective - Digital Journal

Earnings Miss: Is Lixte Biotechnology Holdings Inc stock forming a triangle pattern2025 Retail Activity & Daily Profit Maximizing Trade Tips - baoquankhu1.vn

Market Overview: What makes Lixte Biotechnology Holdings Inc. Equity Warrant stock attractive todayJuly 2025 Breakouts & Safe Capital Growth Plans - baoquankhu1.vn

Retail Trends: Is Lixte Biotechnology Holdings Inc a stock for growth or value investors2025 Analyst Calls & AI Powered Buy and Sell Recommendations - baoquankhu1.vn

LIXTE Biotechnology Holdings (LIXT) Advances a Novel Approach to Enhancing Cancer Therapy - NewMediaWire

12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga

DealFlow Discovery Conference Announces Initial Lineup of Presenting Companies Ahead of Next Week's Event - The Globe and Mail

LIXTE Biotechnology Holdings (NASDAQ: LIXT) Advances a Novel Approach to Enhancing Cancer Therapy - Digital Journal

Datavault AI (NASDAQ: DVLT) Closes Acquisition of API Media Innovation - financial-news.co.uk

De La Soul Set to Lead Good Health Summit at Morehouse College - EBONY Magazine

Stop Loss: Can C3is Inc weather a recessionEarnings Overview Summary & Safe Capital Growth Plans - baoquankhu1.vn

LIXTE Biotechnology Advances Novel Cancer Therapy Approach Targeting PP2A Enzyme - citybuzz -

Spartan Capital Securities, LLC Proudly Serves as Placement Agent in Lixte Biotechnology Holdings, Inc.'s $4.3 Million Registered Direct Offering - Big News Network.com

Highs Report: What makes Lixte Biotechnology Holdings Inc Equity Warrant stock attractive today2025 Growth vs Value & AI Powered Market Entry Ideas - baoquankhu1.vn

Is Lixte Biotechnology Holdings Inc stock a value trapFed Meeting & AI Forecasted Entry and Exit Points - baoquankhu1.vn

LIXTE Biotechnology Holdings (LIXT) Sponsors Good Health Mind, Body and Soul Summit - Yahoo Finance

LIXTE Biotechnology Holdings (NASDAQ: LIXT) Sponsors Good Health Mind, Body and Soul Summit - Digital Journal

LIXTE Biotechnology Sponsors Health Equity Summit at Morehouse College, Linking Cancer Research to Community Wellness - citybuzz -

De La Soul's 'Good Health' summit targets Black men's wellness - Stock Titan

DE LA SOUL-LED “GOOD HEALTH SUMMIT” LAUNCHES FEBRUARY 19 AT MOREHOUSE COLLEGE - The Globe and Mail

Lixte Biotechnology to Present at DealFlow Discovery Conference as Clinical Trials Advance - citybuzz -

LIXTE Biotechnology Attending the DealFlow Discovery Conference, January 28-29 - manilatimes.net

How Lixte Biotechnology Holdings Inc. stock compares to growth peersSector Performance Review & Rapid Portfolio Trading - Bollywood Helpline

Is Lixte Biotechnology Holdings Inc. a stock for growth or value investorsQuarterly Earnings Summary & Real-Time Volume Trigger Notifications - bollywoodhelpline.com

Breakout Move: Can Arvinas Inc grow without external fundingJuly 2025 Spike Watch & Precise Buy Zone Identification - baoquankhu1.vn

Aug Movers: Is OPAD a play on infrastructure spending2025 Trade Ideas & Expert Approved Trade Ideas - baoquankhu1.vn

Pullback Watch: Whats the profit margin of Lixte Biotechnology Holdings IncJuly 2025 Action & Growth Oriented Trading Recommendations - baoquankhu1.vn

Institution Moves: How Lixte Biotechnology Holdings Inc stock performs after earningsJuly 2025 Market Mood & Low Volatility Stock Suggestions - Bộ Nội Vụ

LIXTE Biotechnology Engages IBN to Amplify Communications for Cancer Therapy Development - citybuzz -

About Us - FinancialContent

LIXTE Biotechnology (LIXT) Enhances Visibility with New Communications Strategy - GuruFocus

IBN Initiates Coverage of LIXTE Biotechnology Holdings Inc. - The Manila Times

Breakout Zone: Can Lixte Biotechnology Holdings Inc Equity Warrant withstand a market correctionPortfolio Gains Summary & Low Risk High Win Rate Stock Picks - baoquankhu1.vn

Weekly Trades: How Lixte Biotechnology Holdings Inc stock compares to growth peersEarnings Performance Report & Real-Time Buy Signal Notifications - Bộ Nội Vụ

Is Lixte Biotechnology Holdings Inc. stock trading at a premium valuationTreasury Yields & Expert-Curated Trade Recommendations - ulpravda.ru

Will Lixte Biotechnology Holdings Inc. stock see insider buyingTake Profit & Smart Swing Trading Techniques - Улправда

Is Lixte Biotechnology Holdings Inc. stock a buy before product launchesPortfolio Return Summary & Entry and Exit Point Strategies - ulpravda.ru

Should I hold or sell Lixte Biotechnology Holdings Inc. stock in 2025Weekly Investment Summary & Accurate Technical Buy Alerts - Улправда

Can Lixte Biotechnology Holdings Inc. (8640) stock ride next bull market cycleQuarterly Market Review & Technical Buy Zone Confirmation - Улправда

LIXTE Biotechnology Holdings (LIXT) Expands Ovarian Cancer Trial With MD Anderson and GSK - NewMediaWire

Will Lixte Biotechnology Holdings Inc. (8640) stock beat revenue estimatesFed Meeting & Low Risk Entry Point Tips - Улправда

12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga

Lixte Biotechnology Expands Ovarian Cancer Trial with MD Anderson and GSK - citybuzz -

Will Lixte Biotechnology Holdings Inc. stock benefit from infrastructure spending2025 Volume Leaders & AI Driven Stock Reports - ulpravda.ru

Lixte Biotechnology files to sell 5.26M shares of common stock, warrants - MSN

How strong is Lixte Biotechnology Holdings Inc. Equity Warrant stock revenue growth2025 Trade Ideas & Entry Point Strategy Guides - Улправда

Lixte Biotechnology announces new registered direct offering - MSN

LIXTE Biotechnology Holdings (NASDAQ: LIXT) Expands Ovarian Cancer Trial With MD Anderson and GSK - financial-news.co.uk

Breakout Zone: Why Lixte Biotechnology Holdings Inc. stock is a value investor pickJuly 2025 Weekly Recap & Real-Time Market Sentiment Reports - Улправда

Can Lixte Biotechnology Holdings Inc. stock continue upward trendEarnings Forecast Updates & High Yield Trading Growth - ulpravda.ru

Lixte Biotechnology Holdings (NASDAQ: LIXT) Announces $4.3M Registered Direct Offering Priced at Market - Digital Journal

LIXTE Biotechnology Advances Novel Cancer Treatment Platform Through Clinical Trials and Strategic Moves - citybuzz -

Lixte Biotechnology Holdings Secures $4.3 Million in Registered Direct Offering to Advance Cancer Drug Development - citybuzz -

RPRX

$44.10

0.96%

GMAB

$30.97

2.92%

INCY

$102.76

0.16%

BNTX

$105.54

2.97%

INSM

$151.03

0.92%

ONC

$347.00

1.42%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters